Literature DB >> 6982230

Comparative role of complement in pneumococcal and staphylococcal pneumonia.

J D Coonrod, K Yoneda.   

Abstract

To evaluate the role of complement in pneumococcal and staphylococcal pneumonia, we decomplemented rats with cobra venom factor and inoculated them intratracheally with Staphylococcus aureus or type 25 pneumococci. S. aureus produced a patchy bronchopneumonia in normal Sprague-Dawley or Lewis rats, and decomplementation did not increase the severity of staphylococcal infection in either rat strain as judged by quantitative cultures of the lungs and blood at 6, 24, and 48 h after inoculation. In contrast, decomplementation markedly increased the severity of pneumonia caused by type 25 pneumococci in Sprague-Dawley and Lewis rats. In Sprague-Dawley rats, decomplementation significantly increased the number of bacteria in the lungs at 3, 6, and 24 h of infection. Bacteremia developed early in decomplemented Sprague-Dawley rats, but the higher pulmonary bacterial counts did not appear to be caused by bacteremic seeding of the lungs. Decomplemented Sprague-Dawley rats inoculated intravenously with pneumococci failed to develop the very high levels of bacteria in the lungs that were observed when the rats were inoculated intratracheally. Moreover, decomplemented Lewis rats inoculated intratracheally with pneumococci developed significantly increased numbers of pneumococci in the lungs early in infection (3 and 6 h) when they had no detectable bacteremia. These data indicate that in murine models complement plays a major protective role against type 25 pneumococci in the lung, whereas complement is not important to host defense in staphylococcal pneumonia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982230      PMCID: PMC347674          DOI: 10.1128/iai.37.3.1270-1277.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Functional assay of the alternative complement pathway of rat serum.

Authors:  J D Coonrod; S D Jenkins
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae.

Authors:  J D Coonrod; K Yoneda
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

3.  The effect of intraalveolar fluid on lung bacterial clearance.

Authors:  G D Harris; D E Woods; R Fine; W G Johanson
Journal:  Lung       Date:  1980       Impact factor: 2.584

4.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

5.  Experimental type 25 pneumococcal pneumonia in rats: an electron-microscopic study.

Authors:  K Yoneda; J D Coonrod
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

6.  Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro.

Authors:  D G Hof; J E Repine; P K Peterson; J R Hoidal
Journal:  Am Rev Respir Dis       Date:  1980-01

7.  Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; J Y de Jong-Hoenderop; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

8.  Pulmonary opsonins in Klebsiella pneumoniae pneumonia in rats.

Authors:  J D Coonrod
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

9.  Early bacterial clearance from murine lungs. Species-dependent phagocyte response.

Authors:  S R Rehm; G N Gross; A K Pierce
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  The role of opsonins in recovery from experimental pneumococcal pneumonia.

Authors:  J C Guckian; G D Christensen; D P Fine
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

View more
  7 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

3.  Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats.

Authors:  R B Alcantara; L C Preheim; M J Gentry
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Intrapulmonary growth of Staphylococcus aureus in rats during induced atelectasis.

Authors:  D Frederick; E L Pesanti
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.

Authors:  M C Cerquetti; D O Sordelli; R A Ortegon; J A Bellanti
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

6.  A role for associated transition metals in the immunotoxicity of inhaled ambient particulate matter.

Authors:  Judith T Zelikoff; Kimberly R Schermerhorn; Kaijie Fang; Mitchell D Cohen; Richard B Schlesinger
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

7.  Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.

Authors:  William Bain; Huihua Li; Rick van der Geest; Sara R Moore; Tolani F Olonisakin; Brian Ahn; Erin Papke; Kaveh Moghbeli; Rebecca DeSensi; Sarah Rapport; Melissa Saul; Mei Hulver; Zeyu Xiong; Rama K Mallampalli; Prabir Ray; Alison Morris; Lina Ma; Yohei Doi; Yingze Zhang; Georgios D Kitsios; Hrishikesh S Kulkarni; Bryan J McVerry; Viviana P Ferreira; Mehdi Nouraie; Janet S Lee
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.